The protein has been discussed as a potential serum biomarker for hepatitis B (HBV) and C virus (HCV) induced liver fibrosis. In contrast to our study showing an upregulation in disease conditions in liver and plasma, it was negatively correlated with liver fibrosis severity in human HBV and...
Exclusion criteria included chronic hepatitis B infection, alcohol use >1 drink per day in women and >2 drinks per day in men, and acute infection of any type. An experienced hepatopathologist (L.V.T.) blinded to all clinical data including HIV status reviewed all liver biopsies. Liver ...
Coagulation panel Because the majority of differentially expressed proteins were involved in the coagulation cascade, we assessed the physiological relevance of our DIGE results by testing coagulation parameters in seven LMN horses: another three horses with chronic laminitis were used in addition to the...
Colons from non-treated (day 0) mice, or from mice treated with AOM-DSS for 20 or 52 days were analyzed by LC–MS/MS.aVenn-diagrams representing overlap between differentially expressed proteins upregulated (upper panel) and downregulated (lower panel) in WT vs.Hsf1null colons at different ...
Understanding and management of human diseases should start with and terminate in human observations [113]. Hepatitis, ulcerative colitis, rheumatic fever, typhoid fever, appendicitis, and hyperparathyroidism are all among samples of successful human-human study pathways. ...
For carriers of the hepatitis B virus (HBV), either chemotherapy or immunotherapy agents can increase the risk of HBV reactivation. Although the risk of HBV reactivation has been reported with oral ibrutinib and idelalisib, patients receiving anti-CD20 monoclonal antibody (mAb)-containing regimens, ...